Axxcess Wealth Management, LLC Amgen Inc Transaction History

Axxcess Wealth Management, LLC

$3.9 Billion
Q3 2024

A detailed history of Axxcess Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 14,016 shares of AMGN stock, worth $3.69 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

14,016

Previous 16,442 14.75%

Holding current value

$3.69 Million

Previous $5.14 Million 12.09%

% of portfolio

0.12%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $750,555 - $818,483	-2,426 Reduced 14.75%	14,016 $4.52 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $1.01 Million - $1.22 Million	3,833 Added 30.4%	16,442 $5.14 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $740,199 - $893,513	-2,753 Reduced 17.92%	12,609 $3.58 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $388,152 - $437,882	1,518 Added 10.97%	15,362 $4.42 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $755,217 - $937,622	3,454 Added 33.24%	13,844 $3.72 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $219,626 - $259,704	1,025 Added 10.95%	10,390 $2.31 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $653,887 - $796,979	2,896 Added 44.77%	9,365 $2.26 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $322,703 - $410,033	1,409 Added 27.85%	6,469 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $561,374 - $633,128	2,501 Added 97.73%	5,060 $1.14 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $195,180 - $217,202	-846 Reduced 24.85%	2,559 $622,000
Q1 2022 Aug 11, 2022	BUY	$219.27 - $242.57 $238,565 - $263,916	1,088 Added 46.96%	3,405 $823,000
Q4 2021 Aug 11, 2022	BUY	$198.88 - $227.6 $460,804 - $527,349	2,317 New	2,317 $521,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.

Account

Axxcess Wealth Management, LLC Amgen Inc Transaction History